These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38671070)

  • 1. A novel chemically defined medium for the biotechnological and biomedical exploitation of the cell factory Leishmania tarentolae.
    Cattaneo GM; Varotto-Boccazzi I; Molteni R; Ronchetti F; Gabrieli P; Mendoza-Roldan JA; Otranto D; Montomoli E; Bandi C; Epis S
    Sci Rep; 2024 Apr; 14(1):9562. PubMed ID: 38671070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a defined medium for heterologous expression in Leishmania tarentolae.
    Fritsche C; Sitz M; Wolf M; Pohl HD
    J Basic Microbiol; 2008 Dec; 48(6):488-95. PubMed ID: 18759244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
    Niimi T
    Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins.
    Fritsche C; Sitz M; Weiland N; Breitling R; Pohl HD
    J Basic Microbiol; 2007 Oct; 47(5):384-93. PubMed ID: 17910102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum.
    Habibzadeh S; Doroud D; Taheri T; Seyed N; Rafati S
    Iran Biomed J; 2021 Sep; 25(5):349-58. PubMed ID: 34481426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania tarentolae: Taxonomic classification and its application as a promising biotechnological expression host.
    Klatt S; Simpson L; Maslov DA; Konthur Z
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007424. PubMed ID: 31344033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multisubunit proteins in Leishmania tarentolae.
    Sugino M; Niimi T
    Methods Mol Biol; 2012; 824():317-25. PubMed ID: 22160906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a Leishmania tarentolae strain for site-directed in vivo biotinylation of recombinant proteins.
    Klatt S; Hartl D; Fauler B; Gagoski D; Castro-Obregón S; Konthur Z
    J Proteome Res; 2013 Dec; 12(12):5512-9. PubMed ID: 24093329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Recombinant Trypanosoma cruzi Antigens in Leishmania tarentolae.
    Ferrer MJ; Wehrendt DP; Bonilla M; Comini MA; Tellez-Iñón MT; Potenza M
    Methods Mol Biol; 2019; 1955():105-118. PubMed ID: 30868522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptone-liver (P-L) a new culture medium for the Egyptian Leishmania major.
    Mazyad SA; Abdel-Aziz A
    J Egypt Soc Parasitol; 2003 Apr; 33(1):41-5. PubMed ID: 12739799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly efficient pipeline for protein expression in Leishmania tarentolae using infrared fluorescence protein as marker.
    Dortay H; Mueller-Roeber B
    Microb Cell Fact; 2010 May; 9():29. PubMed ID: 20459748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.
    Niculae A; Bayer P; Cirstea I; Bergbrede T; Pietrucha R; Gruen M; Breitling R; Alexandrov K
    Protein Expr Purif; 2006 Aug; 48(2):167-72. PubMed ID: 16740394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay.
    Baechlein C; Meemken D; Pezzoni G; Engemann C; Grummer B
    J Virol Methods; 2013 Oct; 193(1):238-43. PubMed ID: 23747546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae.
    Hemayatkar M; Mahboudi F; Majidzadeh-A K; Davami F; Vaziri B; Barkhordari F; Adeli A; Mahdian R; Davoudi N
    Biotechnol J; 2010 Nov; 5(11):1198-206. PubMed ID: 21058320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver infusion tryptose (LIT): the best choice for growth, viability, and infectivity of Leishmania infantum parasites.
    Costa AFP; de Brito RCF; Carvalho LM; Cardoso JMO; Vieira PMA; Reis AB; Aguiar-Soares RDO; Roatt BM
    Parasitol Res; 2020 Dec; 119(12):4185-4195. PubMed ID: 33033848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania major: culture media, mouse strains, and promastigote virulence and infectivity.
    Neal RA
    Exp Parasitol; 1984 Jun; 57(3):269-73. PubMed ID: 6723897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae.
    Jørgensen ML; Friis NA; Just J; Madsen P; Petersen SV; Kristensen P
    Microb Cell Fact; 2014 Jan; 13():9. PubMed ID: 24428896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production of recombinant human laminin-332 in a Leishmania tarentolae expression system.
    Phan HP; Sugino M; Niimi T
    Protein Expr Purif; 2009 Nov; 68(1):79-84. PubMed ID: 19607924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium.
    Grekov I; Svobodová M; Nohýnková E; Lipoldová M
    J Microbiol Methods; 2011 Dec; 87(3):273-7. PubMed ID: 21889549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae.
    Turra GL; Schneider L; Liedgens L; Deponte M
    Mol Biochem Parasitol; 2021 Jan; 241():111336. PubMed ID: 33166572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.